» Articles » PMID: 20110383

BASP1 Promotes Apoptosis in Diabetic Nephropathy

Overview
Specialty Nephrology
Date 2010 Jan 30
PMID 20110383
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis contributes to the development of diabetic nephropathy (DN), but the mechanisms that lead to diabetes-induced cell death are not fully understood. Here, we combined a functional genomics screen for cDNAs that induce apoptosis in vitro with transcriptional profiling of renal biopsies from patients with DN. Twelve of the 138 full-length cDNAs that induced cell death in human embryonic kidney cells matched upregulated mRNA transcripts in tissue from human DN. Confirmatory screens identified induction of BASP1 in tubular cross sections of human DN tissue. In vitro, apoptosis-inducing conditions such as serum deprivation, high concentrations of glucose, and proinflammatory cytokines increased BASP1 mRNA and protein in human tubular epithelial cells. In normal cells, BASP1 localized to the cytoplasm, but in apoptotic cells, it colocalized with actin in the periphery. Overexpression of BASP1 induced cell death with features of apoptosis; conversely, small interfering RNA (siRNA)-mediated knockdown of BASP1 protected tubular cells from apoptosis. Supporting possible involvement of BASP1 in renal disease other than DN, we also observed significant upregulation of renal BASP1 in spontaneously hypertensive rats and a trend toward increased tubulointerstitial BASP1 mRNA in human hypertensive nephropathy. In summary, a combined functional genomics approach identified BASP1 as a proapoptotic factor in DN and possibly also in hypertensive nephropathy.

Citing Articles

Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis.

Irvine E, Nikolov A, Khan M, Peters J, Lu R, Sixsmith J Nat Microbiol. 2024; 9(9):2369-2382.

PMID: 39174703 PMC: 11371646. DOI: 10.1038/s41564-024-01777-9.


Oleuropein Supplementation Ameliorates Long-Course Diabetic Nephropathy and Diabetic Cardiomyopathy Induced by Advanced Stage of Type 2 Diabetes in / Mice.

Zheng S, Geng R, Guo J, Kang S, Huang K, Tong T Nutrients. 2024; 16(6).

PMID: 38542759 PMC: 10974438. DOI: 10.3390/nu16060848.


Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective Factors.

Sanchez-Nino M, Ceballos M, Carriazo S, Pintor-Chocano A, Sanz A, Saleem M Int J Mol Sci. 2023; 24(21).

PMID: 37958836 PMC: 10650640. DOI: 10.3390/ijms242115853.


BASP1 expression is associated with poor prognosis and is correlated with immune infiltration in gastric cancer.

Wang T, Liu X, Wang T, Zhan L, Zhang M FEBS Open Bio. 2023; 13(8):1507-1521.

PMID: 37243901 PMC: 10392055. DOI: 10.1002/2211-5463.13654.


Identification of potential biomarkers for ankylosing spondylitis based on bioinformatics analysis.

Li D, Cao R, Dong W, Cheng M, Pan X, Hu Z BMC Musculoskelet Disord. 2023; 24(1):413.

PMID: 37226132 PMC: 10207833. DOI: 10.1186/s12891-023-06550-3.


References
1.
Kelly D, Cox A, Tolcos M, Cooper M, Wilkinson-Berka J, Gilbert R . Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int. 2002; 61(1):31-9. DOI: 10.1046/j.1523-1755.2002.00088.x. View

2.
Mosevitsky M, Capony J, Skladchikova GYu , Novitskaya V, Plekhanov AYu , Zakharov V . The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties. Biochimie. 1997; 79(6):373-84. DOI: 10.1016/s0300-9084(97)80032-6. View

3.
Laux T, Fukami K, Thelen M, Golub T, Frey D, Caroni P . GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol. 2000; 149(7):1455-72. PMC: 2175130. DOI: 10.1083/jcb.149.7.1455. View

4.
Park S, Kim Y, Kim B, Seong C, Oh Y, Baek K . Characterization of bovine and human cDNAs encoding NAP-22 (22 kDa neuronal tissue-enriched acidic protein) homologs. Mol Cells. 1998; 8(4):471-7. View

5.
Engelgau M, Geiss L, Saaddine J, Boyle J, Benjamin S, Gregg E . The evolving diabetes burden in the United States. Ann Intern Med. 2004; 140(11):945-50. DOI: 10.7326/0003-4819-140-11-200406010-00035. View